Fortaleza Asset Management’s Cytokinetics CYTK Stock Holding History

Fortaleza Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-10,345	Closed	-$125K	–	152
2017 Q2	$125K	Sell	10,345 -10,215	-50%	-$142K	0.24%	124
2017 Q1	$264K	Hold	20,560	–	–	0.53%	58
2016 Q4	$250K	Buy	20,560 +545	+3%	+$5.78K	0.53%	62
2016 Q3	$184K	Buy	20,015 +4,085	+26%	+$42.6K	0.26%	75
2016 Q2	$151K	Buy	15,930 +1,930	+14%	+$15.8K	0.12%	81
2016 Q1	$98.7K	Buy	14,000 +5,485	+64%	+$40.1K	0.06%	127
2015 Q4	$89K	Buy	+8,515	New	+$83.5K	0.05%	136
2013 Q4	–	Sell	-42,292	Closed	-$320K	–	219
2013 Q3	$320K	Buy	42,292 +30,488	+258%	+$327K	0.17%	160
2013 Q2	$137K	Buy	+11,804	New	+$93K	0.08%	158

Other funds holding CYTK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

LPU

Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Fortaleza Asset Management's CYTK Position: Q3 2017 in Review

Fortaleza Asset Management sold out of Cytokinetics (CYTK) in Q3 2017, closing a stake of 10,345 shares — an estimated $125K sold.

Fortaleza Asset Management first reported a position in CYTK in Q2 2013 and held it in 9 quarters. The position peaked at $320K in Q3 2013. 132 funds tracked by Wall St. Rank hold CYTK as of Q3 2017.

Fortaleza Asset Management reported no remaining Cytokinetics position as of Q3 2017 after selling out during the quarter.
Fortaleza Asset Management sold 10,345 Cytokinetics shares in Q3 2017, an estimated $125K.
Fortaleza Asset Management first reported a position in Cytokinetics in Q2 2013 and held it in 9 quarters.
Fortaleza Asset Management's Cytokinetics position peaked at $320K in Q3 2013.
132 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2017.

Based on Fortaleza Asset Management's 13F filing for Q3 2017, filed 27 Oct 2017.